Blueprint vs Twofold Health

Distinct from a pure scribe — Blueprint started as a measurement-based-care platform and now ships an ambient note layer that ties session content to outcome measures (PHQ-9, GAD-7, etc.). Useful if you want one tool for both. HIPAA-aligned with BAA. Pricing is published per-clinician with a free trial. Note quality is solid on standard talk-therapy formats; specialty templates are narrower than Mentalyc or Upheal.

Twofold is the standout therapy-native pick in this catalog: purpose-built for behavioral health rather than retrofitted from a generic medical scribe. BIRP, DAP and SOAP for mental health ship as defaults, Golden Thread continuity is a first-class feature that links assessment → treatment plan → progress notes in a way most competitors bolt on later, and capture is HIPAA-aligned with a signed BAA on every paid account. Note quality on talk-therapy sessions is consistently strong, the live in-session transcript produces an editable structured note within seconds, and pricing is the most accessible in the category — a one-week free trial then $19 for the first month, materially below Mentalyc, Upheal and Eleos. Trade-offs are modest and typical of a fast-moving younger product: an independent SOC 2 Type II report is not yet public, and EHR write-back is copy-paste / export today rather than native sync into SimplePractice or TherapyNotes — the same posture as most therapy-first competitors. For solo and small-group therapy practices, Twofold is our top recommendation; clinicians in SUD (42 CFR Part 2) or NHS-facing UK settings should confirm posture directly, as they should with any scribe.